levetiracetam 1g tablets
lupin healthcare (uk - levetiracetam - tablet - 1gram
levetiracetam-lupin
lupin australia pty limited - levetiracetam -
losartan 100mg / hydrochlorothiazide 25mg tablets
lupin healthcare (uk) ltd - hydrochlorothiazide; losartan potassium - oral tablet - 25mg ; 100mg
ropilynz xl 4mg tablets
lupin healthcare (uk) ltd - ropinirole hydrochloride - modified-release tablet - 4mg
ropilynz xl 2mg tablets
lupin healthcare (uk) ltd - ropinirole hydrochloride - modified-release tablet - 2mg
ropilynz xl 8mg tablets
lupin healthcare (uk) ltd - ropinirole hydrochloride - modified-release tablet - 8mg
escilupin
lupin australia pty limited - escitalopram oxalate -
escitalupin
lupin australia pty limited - escitalopram oxalate -
pravastatin-lupin pravastatin sodium 80 mg tablet blister pack
lupin australia pty limited - pravastatin sodium, quantity: 80 mg - tablet, film coated - excipient ingredients: crospovidone; sodium bicarbonate; lactose monohydrate; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; macrogol 8000; purified talc; iron oxide yellow - 1. as an adjunct to diet for the treatment of hypercholesterolaemia. prior to initiating therapy with pravastatin-lupin, secondary causes of hypercholesterolaemia (eg, poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. 2. pravastatin-lupin is indicated in patients with previous myocardial infarction including those who have normal (4.0-5.5 mmol/l) serum cholesterol levels. 3. pravastatin-lupin is indicated in patients with unstable angina pectoris (see clinical trials). 4. pravastatin-lupin is indicated as an adjunct to diet and lifestyle modification for the treatment of heterozygous familial hypercholesterolaemia in children and adolescent patients aged 8 years and older (see clinical trials).
pravastatin-lupin pravastatin sodium 40 mg tablet blister pack
lupin australia pty limited - pravastatin sodium, quantity: 40 mg - tablet, film coated - excipient ingredients: lactose monohydrate; crospovidone; sodium bicarbonate; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; macrogol 8000; purified talc; iron oxide yellow - 1. as an adjunct to diet for the treatment of hypercholesterolaemia. prior to initiating therapy with pravastatin-lupin, secondary causes of hypercholesterolaemia (eg, poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. 2. pravastatin-lupin is indicated in patients with previous myocardial infarction including those who have normal (4.0-5.5 mmol/l) serum cholesterol levels. 3. pravastatin-lupin is indicated in patients with unstable angina pectoris (see clinical trials). 4. pravastatin-lupin is indicated as an adjunct to diet and lifestyle modification for the treatment of heterozygous familial hypercholesterolaemia in children and adolescent patients aged 8 years and older (see clinical trials).